<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="39631f1f-5d19-43c1-b504-bf56d991ed97"><labelDrug name="Vasotec"><Normalization><mmtx cui="C0728763" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></labelDrug><generic name="Enalapril Maleate"/><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.1" text="VASOTEC (enalapril maleate) tablet" type="negative"><entity charOffset="9:26" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.1.e.0" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="(enalapril maleate" preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.1.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.1.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.1.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2" text="VASOTEC (Enalapril Maleate) is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin converting enzyme inhibitor, enalaprilat." type="negative"><entity charOffset="35:60" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.0" text="maleate enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="the maleate salt of enalapril," preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="1426331"/></Normalization></entity><entity charOffset="136:147" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.1" text="enalaprilat" type="Biomedical_Entity"><Normalization><mmtx cui="C0014027" phraseText="enalaprilat." preferredWord="Enalaprilat" semType="phsu, aapp"/><RxNorm RxCui="3829"/></Normalization></entity><entity charOffset="9:26" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.2" text="enalapril maleate" type="Biomedical_Entity"><Normalization><mmtx cui="C0700452" phraseText="(Enalapril Maleate" preferredWord="Enalapril Maleate" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.3" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="95:134" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.4" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="the ethyl ester of a long-acting angiotensin converting enzyme inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.2.e.4"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.4" text="VASOTEC is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema." type="negative"><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.4.e.0" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="161:200" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.4.e.1" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with an angiotensin converting enzyme inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.4.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.4.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5" lineNumber="9" text="Do not coadminister aliskiren with VASOTEC in patients with diabetes (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="20:29" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with VASOTEC" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:42" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.1" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="aliskiren with VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.3" text="Do not coadminister" type="Caution_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.3"><relations><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.2" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.5.e.3" type="Caution_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8" text="Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including VASOTEC) may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="19:59" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.0" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="193:200" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.2" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.8.e.2"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.10" text="Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin converting enzyme inhibitors, including VASOTEC. " type="negative"><entity charOffset="168:175" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.10.e.0" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="116:156" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.10.e.1" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.10.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.10.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.19" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="142:155" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.19.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.19.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.19.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.19.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23" lineNumber="26" text="Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="53:70" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.0" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.1" text="Two patients" type="SPAN"/><entity charOffset="87:101" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:152" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.3" text="anaphylactoid reactions" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.0"/></relation><relation type="hasEvidence"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.2" evidence="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.23.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32" lineNumber="34" text="Patients at risk for excessive hypotension, sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. " type="irregular"><entity charOffset="261:269" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="high dose diuretic therapy," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="31:42" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="70:78" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.3" text="oliguria" type="Specific_Interaction"><Normalization><mmtx cui="C0028961" phraseText="associated with oliguria" preferredWord="Oliguria" semType="sosy"/></Normalization></entity><entity charOffset="98:106" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.5" text="azotemia" type="Specific_Interaction"><Normalization><mmtx cui="C0242528" phraseText="progressive azotemia," preferredWord="Azotemia" semType="dsyn"/><mmtx cui="C0554309" phraseText="progressive azotemia," preferredWord="Prerenal uremia syndrome" semType="dsyn"/></Normalization></entity><entity charOffset="124:143" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.7" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="rarely with acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="151:156" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.9" text="death" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30" text="Patients with heart failure given VASOTEC commonly have some reduction in blood pressure, especially with the first dose, but discontinuation of therapy for continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "><entity charOffset="34:41" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.31" text="caution should be observed when initiating therapy (see DOSAGE AND ADMINISTRATION). "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30" text="Patients with heart failure given VASOTEC commonly have some reduction in blood pressure, especially with the first dose, but discontinuation of therapy for continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "><entity charOffset="34:41" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.31" text="caution should be observed when initiating therapy (see DOSAGE AND ADMINISTRATION). "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.ddi.3"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30" text="Patients with heart failure given VASOTEC commonly have some reduction in blood pressure, especially with the first dose, but discontinuation of therapy for continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "><entity charOffset="34:41" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.31" text="caution should be observed when initiating therapy (see DOSAGE AND ADMINISTRATION). "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.ddi.4"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30" text="Patients with heart failure given VASOTEC commonly have some reduction in blood pressure, especially with the first dose, but discontinuation of therapy for continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "><entity charOffset="34:41" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.31" text="caution should be observed when initiating therapy (see DOSAGE AND ADMINISTRATION). "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.ddi.5"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.9"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30" text="Patients with heart failure given VASOTEC commonly have some reduction in blood pressure, especially with the first dose, but discontinuation of therapy for continuing symptomatic hypotension usually is not necessary when dosing instructions are followed; "><entity charOffset="34:41" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.30.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="Patients with heart failure given VASOTEC commonly" preferredWord="Vasotec" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.31" text="caution should be observed when initiating therapy (see DOSAGE AND ADMINISTRATION). "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.32.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33" text="It may be advisable to eliminate the diuretic (except in patients with heart failure), reduce the diuretic dose or increase salt intake cautiously before initiating therapy with VASOTEC in patients at risk for excessive hypotension who are able to tolerate such adjustments (see PRECAUTIONS, Drug Interactions and ADVERSE REACTIONS). " type="negative"><entity charOffset="98:106" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic dose" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="37:45" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:185" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.2" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="increase salt intake cautiously before initiating therapy with VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.33.e.2"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.34" text="In patients at risk for excessive hypotension, therapy should be started under very close medical supervision and such patients should be followed closely for the first two weeks of treatment and whenever the dose of enalapril and/or diuretic is increased. " type="negative"><entity charOffset="217:226" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.34.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="the dose of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="234:242" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.34.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.34.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.34.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.38" text="If symptomatic hypotension develops, a dose reduction or discontinuation of VASOTEC or concomitant diuretic may be necessary." type="negative"><entity charOffset="99:107" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.38.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="concomitant diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="76:83" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.38.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="discontinuation of VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.38.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.38.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.40" text="Another angiotensin converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients but more frequently in patients with renal impairment especially if they also have a collagen vascular disease. " type="negative"><entity charOffset="8:47" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.40.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="Another angiotensin converting enzyme inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="49:58" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.40.e.1" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.40.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.40.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="198:221" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.55.e.2"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.69" text="As with all vasodilators, enalapril should be given with caution to patients with obstruction in the outflow tract of the left ventricle." type="negative"><entity charOffset="12:24" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.69.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="As with all vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.69.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.69.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.69.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.71" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="41:52" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.71.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="53:64" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.71.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.71.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.71.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72" text="In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin converting enzyme inhibitors, including VASOTEC, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death (see PRECAUTIONS, Drug Interactions)." type="negative"><entity charOffset="198:205" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.0" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC," preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="99:110" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="146:186" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.2" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="111:122" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.3" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.72.e.2"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.74" text="These increases were almost always reversible upon discontinuation of enalapril and/or diuretic therapy. " type="negative"><entity charOffset="87:95" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.74.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.74.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="almost always reversible upon discontinuation of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.74.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.74.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76" lineNumber="70" text="Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when VASOTEC has been given concomitantly with a diuretic. " type="regular"><entity charOffset="208:215" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.0" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="252:260" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="117:140" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.2" text="increases in blood urea" type="Specific_Interaction"/><entity charOffset="117:129|145:161" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.4" text="increases in serum creatinine" type="Specific_Interaction"/><entity charOffset="19:31" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.6" text="hypertension" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="Some patients with hypertension" preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><entity charOffset="35:48" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.7" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="54:101" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.8" text="no apparent pre-existing renal vascular disease" type="SPAN"><Normalization><mmtx cui="C0268790" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/><mmtx cui="C0268790" phraseText="heart failure with no apparent pre-existing renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.2"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.4"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.7"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.6, Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.7, Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.8" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.76.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78" lineNumber="70" text="Dosage reduction and/or discontinuation of the diuretic and/or VASOTEC may be required." type="regular"><entity charOffset="0:16" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.0" text="Dosage reduction" type="Caution_Interaction"/><entity charOffset="24:39" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.2" text="discontinuation" type="Caution_Interaction"/><entity charOffset="47:55" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.4" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:70" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.5" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.0"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.2"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.5" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.78.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85" lineNumber="78" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes, which should be used cautiously, if at all, with VASOTEC (see Drug Interactions)." type="regular"><entity charOffset="36:48" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="124:151" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.2" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.3" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.4" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="270:277" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.5" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="with VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.5" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.5" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.5" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.85.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90" lineNumber="86" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, enalapril may block angiotensin II formation secondary to compensatory renin release. " type="regular"><entity charOffset="63:94" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.0" text="agents that produce hypotension" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="96:105" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.1" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="110:140" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.2" text="block angiotensin II formation" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.91" lineNumber="86" text="If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion." type="irregular"><entity charOffset="3:14" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.91.e.0" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.91.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.91.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, enalapril may block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, enalapril may block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.90.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.94" text="Angioedema, including laryngeal edema, may occur at any time during treatment with angiotensin converting enzyme inhibitors, including enalapril. " type="negative"><entity charOffset="135:144" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.94.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="83:123" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.94.e.1" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.94.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.94.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.103" text="Patients should be told not to use salt substitutes containing potassium without consulting their physician." type="negative"><entity charOffset="63:72" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.103.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="35:51" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.103.e.1" text="salt substitutes" type="Biomedical_Entity"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="9547"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.103.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.103.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="27:38" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115" lineNumber="116" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110" text="NOTE: As with many other drugs, certain advice to patients being treated with enalapril is warranted. "><entity charOffset="78:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="treated with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.111" text="This information is intended to aid in the safe and effective use of this medication. "/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.112" text="It is not a disclosure of all possible adverse or intended effects."/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.113" text="Drug Interactions"/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110" text="NOTE: As with many other drugs, certain advice to patients being treated with enalapril is warranted. "><entity charOffset="78:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="treated with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.111" text="This information is intended to aid in the safe and effective use of this medication. "/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.112" text="It is not a disclosure of all possible adverse or intended effects."/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.113" text="Drug Interactions"/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.ddi.3"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110" text="NOTE: As with many other drugs, certain advice to patients being treated with enalapril is warranted. "><entity charOffset="78:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="treated with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.111" text="This information is intended to aid in the safe and effective use of this medication. "/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.112" text="It is not a disclosure of all possible adverse or intended effects."/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.113" text="Drug Interactions"/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.ddi.4"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110" text="NOTE: As with many other drugs, certain advice to patients being treated with enalapril is warranted. "><entity charOffset="78:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.110.e.0" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="treated with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.111" text="This information is intended to aid in the safe and effective use of this medication. "/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.112" text="It is not a disclosure of all possible adverse or intended effects."/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.113" text="Drug Interactions"/><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.114" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.115.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116" lineNumber="116" text="Closely monitor blood pressure, renal function, and electrolytes in patients on VASOTEC and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="80:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.2" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="on VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="98:124" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.0"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.116.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117" lineNumber="118" text="Do not coadminister aliskiren with VASOTEC in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with VASOTEC" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:42" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.3" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="aliskiren with VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.4" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.117.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118" lineNumber="118" text="Avoid use of aliskiren with VASOTEC in patients with renal impairment (GFR &lt;60 mL/min)." type="regular"><entity charOffset="0:9" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.0" text="Avoid use" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:35" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.3" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="with VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="53:69" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.4" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.118.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120" lineNumber="122" text="Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril. " type="regular"><entity charOffset="12:21" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Patients on diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="124:161" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.1" text="excessive reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="195:204" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.3" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="with enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.1"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.120.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121" text="The possibility of hypotensive effects with enalapril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril. " type="negative"><entity charOffset="44:53" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="with enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="99:107" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="176:185" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.2" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="with enalapril." preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.121.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124" lineNumber="126" text="The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release (e.g., diuretics)." type="regular"><entity charOffset="55:103" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.0" text="antihypertensive agents that cause renin release" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="augmented by antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><mmtx cui="C0035100" phraseText="renin release" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="111:120" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.1" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="31:38" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.3" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="The antihypertensive effect of VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="4:27|42:51" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.4" text="antihypertensive effect augmented" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.1"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.0" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.124.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="0:38" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.0" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.1" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><entity charOffset="88:104" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.2" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.125.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126" lineNumber="130" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including enalapril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="141:147" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:206" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.3" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="218:227" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.4" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril," preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="243:274" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.6" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="295:314" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.8" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="20:27" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.10" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.11" text="volume-depleted" type="SPAN"/><entity charOffset="92:118" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.12" text="compromised renal function" type="SPAN"/><classClassMembership drugClass="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.1"/><drugClassMembership drug="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.4" drugClass="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.3"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.6"><relations><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.12"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.8"><relations><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.12"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.11"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.12, Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.10, Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.11" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.126.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128" lineNumber="130" text="Monitor renal function periodically in patients receiving enalapril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.128.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129" text="In a clinical pharmacology study, indomethacin or sulindac was administered to hypertensive patients receiving VASOTEC. " type="negative"><entity charOffset="50:58" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.0" text="sulindac" type="Biomedical_Entity"><Normalization><mmtx cui="C0038792" phraseText="sulindac" preferredWord="Sulindac" semType="phsu, orch"/><RxNorm RxCui="10237"/></Normalization></entity><entity charOffset="111:118" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="34:46" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.2" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="indomethacin" preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.129.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.130" text="In this study there was no evidence of a blunting of the antihypertensive action of VASOTEC. " type="negative"><entity charOffset="57:73" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.130.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="no evidence of a blunting of the antihypertensive action of VASOTEC." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="84:91" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.130.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="no evidence of a blunting of the antihypertensive action of VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.130.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.130.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131" lineNumber="132" text="However, reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors." type="regular"><entity charOffset="30:36" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="that NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="81:95" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the antihypertensive effect of ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="41:77" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.2" text="diminish the antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.131.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133" text="VASOTEC has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions." type="negative"><entity charOffset="147:154" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin without evidence of clinically significant adverse interactions." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="121:132" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1" text="hydralazine" type="Biomedical_Entity"><Normalization><mmtx cui="C0020223" phraseText="hydralazine," preferredWord="Hydralazine" semType="phsu, orch"/><RxNorm RxCui="5470"/></Normalization></entity><entity charOffset="41:72" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" text="beta adrenergic-blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="concomitantly with beta adrenergic-blocking agents," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="134:142" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4" text="prazosin" type="Biomedical_Entity"><Normalization><mmtx cui="C0032912" phraseText="prazosin" preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="96:103" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="calcium-blocking agents," preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="74:84" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6" text="methyldopa" type="Biomedical_Entity"><Normalization><mmtx cui="C0025741" phraseText="methyldopa," preferredWord="Methyldopa" semType="phsu, aapp, nsba"/><RxNorm RxCui="6876"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.3" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.6" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.133.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135" lineNumber="140" text="VASOTEC attenuates potassium loss caused by thiazide-type diuretics. " type="regular"><entity charOffset="44:67" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.0" text="thiazide-type diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide-type diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.1" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="8:33" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.2" text="attenuates potassium loss" type="Specific_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.0" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136" text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. " type="negative"><entity charOffset="51:62" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="35:49" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" text="spironolactone" type="Biomedical_Entity"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="0:27" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" text="potassium-sparing diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0304490" phraseText="Potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="186:195" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="in serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4" text="amiloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="79:100" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5" text="potassium supplements" type="Biomedical_Entity"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="126:142" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6" text="salt substitutes" type="Biomedical_Entity"><Normalization><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="105:114" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.3"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.4" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.6"/></sentence><sentence biomedicalEntities="0" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137" lineNumber="140" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136" Text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="0:27" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.0" text="Potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136" Text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="79:100" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.7" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136" Text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/><anaphoraEntity charOffset="33:45" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.2" text="these agents" type="Expression"/><antecedentEntity charOffset="105:142" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136.e.8" text="potassium-containing salt substitutes" type="Substance"/></anaphoraRelation><entity charOffset="147:157" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.0" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135" text="VASOTEC attenuates potassium loss caused by thiazide-type diuretics. "><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.135.e.1"/></ellipsisSentence><middleSentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.136" text="Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.137.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138" lineNumber="140" text="Potassium sparing agents should generally not be used in patients with heart failure receiving VASOTEC." type="regular"><entity charOffset="0:24" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.0" text="Potassium sparing agents" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="Potassium sparing agents" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C1254351" phraseText="Potassium sparing agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="95:102" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.1" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="with heart failure receiving VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><mmtx cui="C0728763" phraseText="with heart failure receiving VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="71:84" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.2" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="with heart failure receiving VASOTEC." preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="with heart failure receiving VASOTEC." preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="42:53" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.3" text="not be used" type="Caution_Interaction"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.2" ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.1" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.138.e.3" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140" lineNumber="144" text="Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. " type="regular"><entity charOffset="84:123" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.0" text="drugs which cause elimination of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="lithium concomitantly with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="elimination of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="8:16" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.3" text="toxicity" type="Increase_Interaction"/><entity charOffset="0:7" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.5" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><classClassMembership drugClass="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.1"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.5" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.0" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.140.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141" lineNumber="144" text="A few cases of lithium toxicity have been reported in patients receiving concomitant VASOTEC and lithium and were reversible upon discontinuation of both drugs. " type="regular"><entity charOffset="15:22" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.0" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="A few cases of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="85:92" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.3" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="concomitant VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="3:11" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.4" text="ew cases" type="SPAN"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.1"><relations><relation type="hasEvidence"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.3" evidence="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.4" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.141.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142" lineNumber="144" text="It is recommended that serum lithium levels be monitored frequently if enalapril is administered concomitantly with lithium." type="regular"><entity charOffset="47:56" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="71:80" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.2" text="enalapril" type="Drug"><Normalization><mmtx cui="C0014025" phraseText="enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="116:123" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.0"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.2" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.3" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.142.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144" lineNumber="148" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC." type="regular"><entity charOffset="199:212" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="231:238" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.1" text="VASOTEC" type="Drug"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC." preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.3" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="38:53" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.5" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="55:61" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.7" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.9" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="76:87" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.11" text="hypotension" type="Specific_Interaction"/><entity charOffset="160:181" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><drugClassMembership drug="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.1" drugClass="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.ddi.1"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.3"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.ddi.2"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.5"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.ddi.3"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.7"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.ddi.4"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.9"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.ddi.5"><interaction trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.11"><relations><relation type="hasObject"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.13" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.0" trigger="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.144.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.150" text="There were no adverse effects on reproductive performance of male and female rats treated with up to 90 mg/kg/day of enalapril (26 times the MRHDD when compared on a body surface area basis)." type="negative"><entity charOffset="184:189" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.150.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="117:126" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.150.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="of enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.150.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.150.e.0"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153" text="Enalapril and enalaprilat have been detected in human breast milk. " type="negative"><entity charOffset="14:25" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.0" text="enalaprilat" type="Biomedical_Entity"><Normalization><mmtx cui="C0014027" phraseText="enalaprilat" preferredWord="Enalaprilat" semType="phsu, aapp"/><RxNorm RxCui="3829"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.1" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="Enalapril" preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="48:65" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.2" text="human breast milk" type="Biomedical_Entity"><Normalization><mmtx cui="C0885503" phraseText="detected in human breast milk." preferredWord="human breast milk" semType="phsu, orch"/><RxNorm RxCui="831503"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.0"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.2"/><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.1" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.153.e.2"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.154" text="Because of the potential for serious adverse reactions in nursing infants from enalapril, a decision should be made whether to discontinue nursing or to discontinue VASOTEC, taking into account the importance of the drug to the mother." type="negative"><entity charOffset="79:88" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.154.e.0" text="enalapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0014025" phraseText="from enalapril," preferredWord="Enalapril" semType="phsu, aapp"/><RxNorm RxCui="203123"/></Normalization></entity><entity charOffset="165:172" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.154.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="VASOTEC," preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.154.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.154.e.1"/></sentence><sentence id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.160" text="Antihypertensive effects of VASOTEC have been established in hypertensive pediatric patients age 1 month to 16 years. " type="negative"><entity charOffset="0:16" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.160.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="Antihypertensive effects of VASOTEC" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="28:35" id="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.160.e.1" text="vasotec" type="Biomedical_Entity"><Normalization><mmtx cui="C0728763" phraseText="Antihypertensive effects of VASOTEC" preferredWord="Vasotec" semType="phsu, aapp"/><RxNorm RxCui="224921"/></Normalization></entity><pair ddi="false" e1="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.160.e.0" e2="Dailymed.39631f1f-5d19-43c1-b504-bf56d991ed97.s.160.e.1"/></sentence><positiveExamples number="27"/><negativeExamples number="102"/></document>